ArticleScientific reports2020
Extracellular NAD
Open access · goldAbstract read
In one paragraph
Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.
0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
66 citing papers in PubMed, 90 citations in OpenAlex.
- Repair of single-strand breaks during the cell cycle - saturation of repair capacity.Nucleus (Austin, Tex.) · 2026Article
- MAP2K6 reprograms NADCell death & disease · 2026Article
- Exosomal Profiling Reveals Mechanisms of Hibernation-Associated Neuroprotection.bioRxiv : the preprint server for biology · 2026Article
- Targeting the NADTrends in molecular medicine · 2026Review
- Intracellular NADJournal of cellular and molecular medicine · 2026Article
- Shaping death: how the microbiome regulates tumour cell demise and therapy response.Cancer metastasis reviews · 2026Review
- Characterizing the tuberculosis and type 2 diabetes mellitus comorbidity in a South African cohort using untargeted GCxGC-TOFMS metabolomics.Metabolomics : Official journal of the Metabolomic Society · 2026Article
- TAT-PBX1 Reverses Hyperglycemia Through β-Cell Regeneration and Functional Restoration in an STZ-Induced Diabetic Model.Pharmaceuticals (Basel, Switzerland) · 2026Article
- Narrative review of intravenous NADFrontiers in aging · 2026Review
- Cockayne syndrome mice reflect human kidney disease and are defective in de novo NAD biosynthesis.Cell death and differentiation · 2025Article
- AAV Kills Dividing Cells by Depleting PARP1 and Other DNA Damage Response Proteins.bioRxiv : the preprint server for biology · 2025Article
- Deciphering enemy tactics - the narrow path to an optimal anti-cancer strategy targeting the Warburg effect.Pharmacological reports : PR · 2025Review
- Epigenetic Regulation of Aging and its Rejuvenation.MedComm · 2025Review
- Oral nicotinamide mononucleotide (NMN) increases tissue NADPhotochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2025Article
- Fis1 regulates mitochondrial morphology, bioenergetics and removal of mitochondrial DNA damage in irradiated glioblastoma cells.Journal of cell science · 2025Article
- Nicotinamide riboside and nicotinamide mononucleotide facilitate NADScience advances · 2025Article
- A Novel Insight into the Role of Obesity-Related Adipokines in Ovarian Cancer-State-of-the-Art Review and Future Perspectives.International journal of molecular sciences · 2025Review
- Apigenin protects ischemic stroke by regulating intestinal microbiota homeostasis, regulates brain metabolic profile.Frontiers in pharmacology · 2025Article
- Assessing changes in ultraviolet radiation-exposed mouse skin using optical coherence tomography.PloS one · 2025Article
- Oxidative genomic or genotoxic stress in neurodegeneration: Mechanisms and therapeutic avenues.AIMS neuroscience · 2025Review
6 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors at 3 institutions in 3 countries.
Anna WilkMitchell Cancer Institute, University of South Alabama, Mobile, AL, 36604, USA.ORCID http://orcid.org/0000-0002-9444-7051
Faisal HayatMitchell Cancer Institute, University of South Alabama, Mobile, AL, 36604, USA.
Richard CunninghamMitchell Cancer Institute, University of South Alabama, Mobile, AL, 36604, USA.
Jianfeng LiMitchell Cancer Institute, University of South Alabama, Mobile, AL, 36604, USA.
Silvia GaravagliaDepartment of Pharmaceutical Sciences, University of Piemonte Orientale, Largo Donegani 2, 28100, Novara, Italy.
Leila ZamaniMitchell Cancer Institute, University of South Alabama, Mobile, AL, 36604, USA.
Davide M FerrarisDepartment of Pharmaceutical Sciences, University of Piemonte Orientale, Largo Donegani 2, 28100, Novara, Italy.ORCID http://orcid.org/0000-0001-5112-9910
Peter SykoraMitchell Cancer Institute, University of South Alabama, Mobile, AL, 36604, USA.
Joel AndrewsMitchell Cancer Institute, University of South Alabama, Mobile, AL, 36604, USA.
Jennifer ClarkMitchell Cancer Institute, University of South Alabama, Mobile, AL, 36604, USA.
Amanda DavisMitchell Cancer Institute, University of South Alabama, Mobile, AL, 36604, USA.
Laurent ChaloinInstitut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, CNRS, 34293, Montpellier, France.
Menico RizziDepartment of Pharmaceutical Sciences, University of Piemonte Orientale, Largo Donegani 2, 28100, Novara, Italy.
Marie MigaudMitchell Cancer Institute, University of South Alabama, Mobile, AL, 36604, USA.
Robert W SobolMitchell Cancer Institute, University of South Alabama, Mobile, AL, 36604, USA. rwsobol@health.southalabama.edu.ORCID http://orcid.org/0000-0001-7385-3563
USA Mitchell Cancer Institute · USUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITCentre National de la Recherche Scientifique · FR
Funding
A Systems Approach to Mapping the DNA Damage ResponseR01ES014811 · NIEHS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI IDEKER, TREY · 2005 to 2021
$8.6MNovel approaches to enhance tumor cell cytotoxicity of alkylating agentsR01CA148629 · NCI · UNIVERSITY OF SOUTH ALABAMA · PI SOBOL, ROBERT W · 2010 to 2021
$3.4MMeasuring genomic DNA damage and DNA repair capacity in longitudinal population samples - a step towards precision preventionU01ES029518 · NIEHS · UNIVERSITY OF SOUTH ALABAMA · PI SOBOL, ROBERT W · 2018 to 2022
$2.7MNCI NIH HHS R01 CA148629NIEHS NIH HHS R01 ES014811NIEHS NIH HHS U01 ES029518
Abstract
Changes in nicotinamide adenine dinucleotide (NAD
Indexed as
DNA DamageDNA RepairPoly ADP Ribosylation5'-NucleotidaseGene ExpressionGene Expression Regulation, NeoplasticHumansMCF-7 CellsMitochondriaNADPoly(ADP-ribose) PolymerasesReactive Oxygen SpeciesSirtuinsTumor MicroenvironmentX-ray Repair Cross Complementing Protein 15'-NucleotidaseNADPoly(ADP-ribose) PolymerasesReactive Oxygen SpeciesSirtuinsX-ray Repair Cross Complementing Protein 1XRCC1 protein, human
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.